SCHEMBL9681025

SCHEMBL9681025

O=C(O)C1CCC(c2ccc(Cl)c(Cl)c2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.56
RAB9A P51151 1/20 0.56
PDE4A P27815 1/20 0.48
PDE4B Q07343 1/20 0.48
PDE4C Q08493 1/20 0.48
PDE4D Q08499 1/20 0.48
NOTUM Q6P988 1/20 0.48
AKR1C3 P42330 1/20 0.46
AKR1C1 Q04828 1/20 0.46
SLC6A4 P31645 7/20 0.45
SLC6A3 Q01959 7/20 0.45
SLC6A2 P23975 6/20 0.45
KCNH2 Q12809 4/20 0.45
CYP2D6 P10635 3/20 0.45
SMURF2 Q9HAU4 1/20 0.43
SMURF1 Q9HCE7 1/20 0.43
S1PR1 P21453 1/20 0.42
S1PR5 Q9H228 1/20 0.42
MRGPRX4 Q96LA9 1/20 0.42
KMO O15229 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24524132 0.85 NPC1 (0.51) NPC1RAB9APDE4APDE4BPDE4C
SCHEMBL5024448 0.85 NPC1 (0.51) NPC1RAB9APDE4APDE4BPDE4C
SCHEMBL14113414 0.83 CCNA2 (0.47) NPC1RAB9ASLC6A4SLC6A3SLC6A2
SCHEMBL3303309 0.83 CCNA2 (0.47) NPC1RAB9ASLC6A4SLC6A3SLC6A2
SCHEMBL3303305 0.83 CCNA2 (0.47) NPC1RAB9ASLC6A4SLC6A3SLC6A2
SCHEMBL9870878 0.83 SLC6A2 (0.58) NPC1RAB9ASLC6A4SLC6A3SLC6A2
SCHEMBL637532 0.80 NPC1 (0.66) NPC1RAB9APDE4APDE4BPDE4C
SCHEMBL918204 0.80 NPC1 (0.66) NPC1RAB9APDE4APDE4BPDE4C
SCHEMBL3302158 0.79 KDM4E (0.57) NPC1RAB9A
SCHEMBL3302163 0.79 KDM4E (0.57) NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5175319-A Antiprotozoa agent, useful for treating malaria, theileriosis, coccidiosis and prophylaxix BURROUGHS WELLCOME CO. (US) 1992-12-29 US disclosed
US-5053432-A Antiprotozoa agents; treatment of malaria BURROUGHS WELLCOME CO. (US) 1991-10-01 US disclosed
EP-0123238-B1 NAPHTHOQUINONE DERIVATIVES THE WELLCOME FOUNDATION LIMITED (GB) 1987-06-10 EP disclosed